These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Travelers' diarrhea]. Regamey C Schweiz Med Wochenschr; 1984 Jul; 114(29):1022-4. PubMed ID: 6474127 [TBL] [Abstract][Full Text] [Related]
64. Inflammatory bowel disease masquerading as traveller's diarrhoea. Stewart A; Sowden D; Sloss A; Broom J Intern Med J; 2019 Jun; 49(6):789-791. PubMed ID: 31185525 [TBL] [Abstract][Full Text] [Related]
65. [Loperamide for acute infectious diarrhoea]. Douma JA; Smulders YM Ned Tijdschr Geneeskd; 2015; 159():A9132. PubMed ID: 26246063 [TBL] [Abstract][Full Text] [Related]
66. Prevention of traveller's diarrhea with doxycycline. Armstrong JB Can Med Assoc J; 1979 Apr; 120(7):794-5. PubMed ID: 427684 [No Abstract] [Full Text] [Related]
67. Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance. Vila J; Vargas M; Ruiz J; Espasa M; Pujol M; Corachán M; Anta MTJ; Gascón J J Med Microbiol; 2001 Nov; 50(11):996-1000. PubMed ID: 11699598 [TBL] [Abstract][Full Text] [Related]
68. Rifamycin SV MMX Hoy SM Clin Drug Investig; 2019 Jul; 39(7):691-697. PubMed ID: 31172447 [TBL] [Abstract][Full Text] [Related]
70. Multiplex PCR reveals a high prevalence of multiple pathogens in traveller's diarrhoea in children. Pouletty M; De Pontual L; Lopez M; Morin L; Poilane I; Pham LL; Carbonnelle E; Titomanlio L; Faye A; Bonacorsi S Arch Dis Child; 2019 Feb; 104(2):141-146. PubMed ID: 29982173 [TBL] [Abstract][Full Text] [Related]
71. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study. Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840 [TBL] [Abstract][Full Text] [Related]
72. "In vitro" study of sulfimidazole, trimethoprim and fluoroquinolones in traveller's bowel infections. Castelli M; Baggio G; Ruberto AI; Provvisionato A; Malagoli M; Bossa R; Galatulas I G Ital Chemioter; 1991; 38(1-3):105-6. PubMed ID: 1365554 [No Abstract] [Full Text] [Related]
74. The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli. Porter CK; Riddle MS; Tribble DR; Putnam SD; Rockabrand DM; Frenck RW; Rozmajzl P; Kilbane E; Fox A; Ruck R; Lim M; Johnston J; Murphy E; Sanders JW Diagn Microbiol Infect Dis; 2010 Mar; 66(3):241-7. PubMed ID: 19903582 [TBL] [Abstract][Full Text] [Related]
75. [Epidemiologic, clinical and microbiological characteristics of enterotoxigenic E. coli as the cause of traveller's diarrhea]. Vila J; Gascón J; Gené A; Ruiz L; Corachán M; Jiménez de Anta MT Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):148-51. PubMed ID: 1576188 [TBL] [Abstract][Full Text] [Related]
76. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea. Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067 [TBL] [Abstract][Full Text] [Related]